Corcept Therapeutics Stock Options
| CORT Stock | USD 58.66 1.07 1.86% |
Corcept Therapeutics' latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.81 with a put-to-call open interest ratio of 1.16 over 44 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on June 20th 2025.
Open Interest Against June 20th 2025 Option Contracts
Corcept Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Corcept Therapeutics' lending market. For example, when Corcept Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Corcept Therapeutics, he or she must hedge the risk by shorting Corcept Therapeutics stock over its option's life.
2025-06-20
The chart above shows Corcept Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Corcept Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Corcept Therapeutics' option, there is no secondary market available for investors to trade.
Corcept Therapeutics Maximum Pain Price Across 2025-06-20 Option Contracts
Max pain occurs when Corcept Therapeutics' market makers reach a net positive position across all Corcept Therapeutics' options at a strike price where option holders stand to lose the most money. By contrast, Corcept Therapeutics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Corcept Therapeutics
Analyzing Corcept Therapeutics' in-the-money options over time can help investors to take a profitable long position in Corcept Therapeutics regardless of its overall volatility. This is especially true when Corcept Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Corcept Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Corcept Therapeutics' stock while costing only a fraction of its price.
Corcept Therapeutics In The Money Call Balance
When Corcept Therapeutics' strike price is surpassing the current stock price, the option contract against Corcept Therapeutics Incorporated stock is said to be in the money. When it comes to buying Corcept Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Corcept Therapeutics Incorporated are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Corcept Current Options Market Mood
Corcept Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Corcept Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Corcept Therapeutics' options investors are not very successful. Corcept Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Corcept contract
Base on the Rule 16, the options market is currently suggesting that Corcept Therapeutics Incorporated will have an average daily up or down price movement of about 0.0506% per day over the life of the 2025-06-20 option contract. With Corcept Therapeutics trading at USD 58.66, that is roughly USD 0.0297. If you think that the market is fully incorporating Corcept Therapeutics' daily price movement you should consider buying Corcept Therapeutics Incorporated options at the current volatility level of 0.81%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Corcept |
Purchasing Corcept Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Corcept calls. Remember, the seller must deliver Corcept Therapeutics Incorporated stock to the call owner when a call is exercised.
Corcept Therapeutics Option Chain
When Corcept Therapeutics' strike price is surpassing the current stock price, the option contract against Corcept Therapeutics Incorporated stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Corcept Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Corcept. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Corcept. It also shows strike prices and maturity days for a Corcept Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | CORT250620C00105000 | 0 | 105.0 | 0.0 - 2.45 | 2.45 | |
Call | CORT250620C00100000 | 2 | 100.0 | 0.0 - 2.65 | 2.85 | Out |
Call | CORT250620C00095000 | 0 | 95.0 | 0.0 - 2.75 | 2.75 | |
Call | CORT250620C00090000 | 26 | 90.0 | 0.0 - 3.2 | 2.55 | Out |
Call | CORT250620C00085000 | 61 | 85.0 | 0.0 - 3.8 | 2.0 | Out |
Call | CORT250620C00080000 | 39 | 80.0 | 1.45 - 2.55 | 1.88 | Out |
Call | CORT250620C00075000 | 36 | 75.0 | 1.25 - 4.6 | 4.2 | Out |
Call | CORT250620C00070000 | 16 | 70.0 | 2.0 - 6.0 | 3.73 | Out |
Call | CORT250620C00065000 | 28 | 65.0 | 5.1 - 6.0 | 6.5 | Out |
Call | CORT250620C00060000 | 338 | 60.0 | 7.0 - 8.1 | 7.4 | Out |
Call | CORT250620C00055000 | 142 | 55.0 | 9.2 - 10.2 | 10.1 | In |
Call | CORT250620C00050000 | 38 | 50.0 | 12.1 - 13.3 | 12.55 | In |
Call | CORT250620C00047000 | 139 | 47.0 | 14.1 - 15.0 | 12.45 | In |
Call | CORT250620C00045000 | 25 | 45.0 | 13.8 - 17.9 | 30.6 | In |
Call | CORT250620C00042000 | 2 | 42.0 | 16.0 - 20.1 | 9.1 | In |
Call | CORT250620C00040000 | 20 | 40.0 | 17.7 - 21.7 | 33.17 | In |
Call | CORT250620C00037000 | 300 | 37.0 | 20.4 - 23.7 | 22.1 | In |
Call | CORT250620C00035000 | 400 | 35.0 | 21.8 - 25.2 | 35.78 | In |
Call | CORT250620C00030000 | 1 | 30.0 | 26.1 - 30.4 | 22.15 | In |
Call | CORT250620C00027000 | 5 | 27.0 | 29.0 - 33.2 | 12.58 | In |
Call | CORT250620C00020000 | 105 | 20.0 | 35.8 - 40.2 | 29.63 | In |
Put | CORT250620P00105000 | 0 | 105.0 | 45.4 - 49.6 | 45.4 | In |
Put | CORT250620P00100000 | 0 | 100.0 | 40.8 - 44.7 | 40.8 | In |
Put | CORT250620P00095000 | 0 | 95.0 | 35.6 - 39.4 | 35.6 | In |
Put | CORT250620P00090000 | 0 | 90.0 | 31.0 - 35.1 | 31.0 | In |
Put | CORT250620P00085000 | 0 | 85.0 | 26.5 - 30.5 | 26.5 | In |
Put | CORT250620P00080000 | 0 | 80.0 | 21.8 - 26.1 | 21.8 | In |
Put | CORT250620P00075000 | 18 | 75.0 | 18.1 - 21.7 | 20.78 | In |
Put | CORT250620P00070000 | 10 | 70.0 | 13.6 - 17.9 | 8.22 | In |
Put | CORT250620P00065000 | 15 | 65.0 | 11.7 - 13.5 | 9.0 | In |
Put | CORT250620P00060000 | 137 | 60.0 | 8.5 - 10.2 | 10.98 | In |
Put | CORT250620P00055000 | 93 | 55.0 | 5.7 - 7.9 | 6.4 | Out |
Put | CORT250620P00050000 | 13 | 50.0 | 2.8 - 6.0 | 5.95 | Out |
Put | CORT250620P00047000 | 4 | 47.0 | 1.65 - 5.2 | 1.71 | Out |
Put | CORT250620P00045000 | 59 | 45.0 | 0.95 - 4.5 | 3.4 | Out |
Put | CORT250620P00042000 | 63 | 42.0 | 0.0 - 3.8 | 3.3 | Out |
Put | CORT250620P00040000 | 46 | 40.0 | 0.0 - 3.5 | 1.2 | Out |
Put | CORT250620P00037000 | 576 | 37.0 | 0.25 - 2.9 | 1.8 | Out |
Put | CORT250620P00035000 | 512 | 35.0 | 0.0 - 2.6 | 1.75 | Out |
Put | CORT250620P00032000 | 50 | 32.0 | 0.0 - 2.35 | 2.45 | Out |
Put | CORT250620P00030000 | 1 | 30.0 | 0.0 - 2.45 | 1.15 | Out |
Put | CORT250620P00025000 | 401 | 25.0 | 0.0 - 2.25 | 1.0 | Out |
Put | CORT250620P00023000 | 1 | 23.0 | 0.0 - 2.2 | 0.9 | Out |
Put | CORT250620P00020000 | 2 | 20.0 | 0.0 - 2.15 | 1.86 | Out |
Corcept Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Corcept Therapeutics Corporate Management
| Hazel Hunt | Chief Officer | Profile | |
| Amy Flood | Chief Officer | Profile | |
| Joseph MD | President, CoFounder | Profile | |
| William PharmD | Chief Officer | Profile | |
| Gary JD | Chief Secretary | Profile |
Additional Tools for Corcept Stock Analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.